Elementis plc ("the Company")
TR-1: Â Â Â Â Â Â Â NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached:
Elementis plc
2. Reason for the notification
An acquisition or disposal of voting rights
3. Full name of person(s) subject to the notification obligation:
AXA S.A. and its group of companies
4. Full name of shareholder(s) (if different from 3):
N/A
5. Date of the transaction (and date on which the threshold is
crossed or reached if different):
28 March 2010
6. Date on which issuer notified:
29 March 2010
7. Threshold(s) that is/are crossed or reached:
5%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares             241854
Situation previous to the Resulting situation after the triggering transaction
Number of shares              22,402,799
Number of Voting Rights         22,402,799
Resulting situation after the triggering transaction
Number of shares Direct              223,240
Number of voting rights  Direct     223,240
Number of voting rights  Indirect     22,192,451
% of voting rightsDirect            0.05
% of voting rightsIndirect           4.95
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ Conversion Period/ Date
Number of voting rights that may be acquired if the instrument is
exercised/ converted
% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Exercise price
Expiration date
Exercise/ Conversion Period
Number of voting rights instrument refers to
% of voting rights
Nominal
Delta
Total (A+B+C)
Number of voting rights      22,415,691
% of voting rights                5.00%
9. Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable:
Name of Company/Fund  Number of Shares  % of issued share capital
AXA IM UK Â Â Â Â Â Â Â Â Â 223,240 Â Â Â Â Â Â Â Â Â 0.049817
Direct
AXA IM UK Â Â Â Â Â Â Â Â Â 22,059,599 Â Â Â Â Â Â Â 4.922659
Indirect
AXA Rosenberg  132,892         0.029655
Indirect
Total Direct  223,240  0.04982
Total Indirect      22,192,451  4.95231
Total      23,415,691  5.00213
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Kyere Tabiri
15. Contact telephone number: Â Â Â Â Â 020 7003 1510
This notification is made in accordance with Rule 5.8.12 R(1) of the Disclosure
and Transparency Rules sourcebook.
Wai Wong
Company Secretary
020 7408 9303
29 March 2010
[HUG#1398949]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.